DNTH vs ETR · rev $6.2M vs P/E 28, rev $12.95B
Dianthus Therapeutics Inc. (DNTH) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
DNTH currently screens at market cap $4.40B. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the DNTH and ETR stock pages for the full models.
Not investment advice.